Hypoglycemia did not occur in all animals during the ITT and fewer T2D rats developed hypoglycemia with PRL-2903 treatment (44%) than with vehicle treatment (66%) (Figure 4B). This evidence concerns the gene PRL and type 2 diabetes mellitus.